Abstract
Background
In some centers, palliative resection (PR; partial pancreaticoduodenectomy) is, in selected cases, promoted in preference to double loop bypass (DLB) surgery for advanced pancreatic cancer. This prospective study compares PR with DLB, placing particular focus on patients’ quality of life (QoL).
Methods
From 01/1993 to 09/2004, 167 patients were analyzed in a prospective single center study of palliative surgical treatment of advanced ductal adenocarcinoma of the pancreatic head. Thirty-eight underwent PR and 129 underwent palliative DLB. Patients undergoing DLB were divided into: (1) locally advanced disease (LAD-subgroup; n = 61; 47%) and (2) metastasized disease (MD-subgroup; n = 68; 53%). QoL was assessed using the EORTC QLQ-C30 questionnaire supplemented by a pancreatic cancer specific module. QoL data were collected pre-operatively and for up to 12 months after surgery.
Results
Median survival was 7.0 months (95% CI 4.09; 9.91) in PR patients and 6.0 months (95% CI 5.39; 6.61) in patients who received DLB. Mortality and morbidity were, respectively, 7.8 and 58% for PR, and 2.6 and 42% for DLB. QoL decreased more after PR than after DLB. The DLB-group recovered quicker, reaching pre-operative QoL levels after 3 months, and were less impaired when discharged. The LAD-subgroup and the MD-subgroup presented with equal levels of QoL.
Conclusions
QoL analysis revealed favorable QoL data after DLB. Additionally, the survival rates of the two groups did not differ significantly, but morbidity and mortality rates in the PR group were elevated. Therefore, the use of PR for advanced pancreatic cancer needs to be carefully evaluated.
Similar content being viewed by others
References
Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54(1):8–29
Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82(1):111–5
Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1–7
Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic g astrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230(3):322–8; discussion 328–30
Kuriansky J, Saenz A, Astudillo E, et al. Simultaneous laparoscopic biliary and retrocolic gastric bypass in patients with unresectable carcinoma of the pancreas. Surg Endosc 2000; 14(2):179–81
Ouchi K, Sugawara T, Ono H, et al. Palliative operation for cancer of the head of the pancreas: significance of pancreaticoduodenectomy and intraoperative radiation therapy for survival and quality of life. World J Surg 1998; 22(4):413–6; discussion 417
Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223(6):718–25; discussion 725–8
Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236(3):355–66; discussion 366–8
Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, et al. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 2005; 92(4):471–7
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5):365–76
Fayers PMAN, Bjordal K, Curran D, Groenvold M. (1999) EORTC QLQ-C30 Scoring manual, 2nd edn.
Kuechler T. Quality of life research in oncology. Quality of life and health: Concepts, methods and applications. Vienna: Blackwell Wissenschafts-Verlag (1995) pp 89–96
Kuechler T. Evaluation of effects of medical/psychological support on survival and quality of life in patients with gastrointestinal tumors—a prospective, randomised trial. Final report to the German Ministry of Technology and Research (BMFT), 1996
Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37(11):1345–51
Berzon RA. Understanding and using health-related quality of life instruments within clinical research studies. In: Fayers PM, Hays RD, (eds). Quality of life assessment in clinical trials—methods and practice. Oxford: Oxford University Press (2005)
Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16(1):139–44
Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363(9414):1049–57
Schwarz A, Beger HG. Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials. Int J Pancreatol 2000; 27(1):51–8
Nuzzo G, Clemente G, Cadeddu F, Giovannini I. Palliation of unresectable periampullary neoplasms. “surgical” versus “non-surgical” approach. Hepatogastroenterology 2004; 51(59):1282–5
Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005; 92(5):547–56
Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4(6):567–79
Kremer B, Vogel I, Luttges J, et al. Surgical possibilities for pancreatic cancer: extended resection. Ann Oncol 1999; 10(Suppl 4):252–6
Lillemoe KD. Primary duodenal adenocarcinoma: role for aggressive resection. J Am Coll Surg 1996; 183(2):155–6
Van Heek NT, De Castro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003; 238(6):894–902; discussion 902–5
McLeod RS. Quality of life, nutritional status and gastrointestinal hormone profile following the Whipple procedure. Ann Oncol 1999; 10(Suppl 4):281–4
Huang JJ, Yeo CJ, Sohn TA, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 2000; 231(6):890–8
Kahlke V, Bestmann B, Schmid A, et al. Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World J Surg 2004; 28(4):369–75
Thybusch-Bernhardt A, Schmidt C, Kuchler T, et al. Quality of life following radical surgical treatment of gastric carcinoma. World J Surg 1999; 23(5):503–8
Schmidt CE, Bestmann B, Kuchler T, et al. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol 2005; 12(2):117–23
Sprangers MA, Van Dam FS, Broersen J, et al. Revealing response shift in longitudinal research on fatigue—the use of the thentest approach. Acta Oncol 1999; 38(6):709–18
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schniewind, B., Bestmann, B., Kurdow, R. et al. Bypass Surgery Versus Palliative Pancreaticoduodenectomy in Patients with Advanced Ductal Adenocarcinoma of the Pancreatic Head, with an Emphasis on Quality of Life Analyses. Ann Surg Oncol 13, 1403–1411 (2006). https://doi.org/10.1245/s10434-006-9172-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-006-9172-z